PLOS Medicine publishes research and commentary of general interest with clear implications for patient care, public policy or clinical research agendas.
*To whom correspondence should be addressed. E-mail: firstname.lastname@example.org
Department of Medical Sciences, Ospedale “Regina Apostolorum,” Albano Laziale, Rome, Italy
Department of Hematology, University of Rome “Tor Vergata,” Rome, Italy
Department of Public Health Science, University of Rome “La Sapienza,” Rome, Italy
Department of Haematology, St Bartholomew's & The Royal London School of Medicine & Dentistry, London, United Kingdom
Post a new comment on this article
Long-Term Outcome of Individuals with Borderline Thrombocytopenia
We want your feedback. Do these subject areas make sense for this article? If not, click the flag
next to the incorrect subject area and we will review it. Thanks for your help!
Authors' replyPosted by plosmedicine
Borderline Thrombocytopenia or Mild ITP?Posted by plosmedicine
Ambra 2.10.17 Managed Colocation provided by Internet Systems Consortium.
Send us feedback
Help using this site